DE69934415D1 - Neuartiges collectin - Google Patents

Neuartiges collectin

Info

Publication number
DE69934415D1
DE69934415D1 DE69934415T DE69934415T DE69934415D1 DE 69934415 D1 DE69934415 D1 DE 69934415D1 DE 69934415 T DE69934415 T DE 69934415T DE 69934415 T DE69934415 T DE 69934415T DE 69934415 D1 DE69934415 D1 DE 69934415D1
Authority
DE
Germany
Prior art keywords
novel collectin
collectin
seq
sequence set
set out
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934415T
Other languages
English (en)
Other versions
DE69934415T2 (de
Inventor
Nobutaka Wakamiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fuso Pharmaceutical Industries Ltd
Original Assignee
Fuso Pharmaceutical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Industries Ltd filed Critical Fuso Pharmaceutical Industries Ltd
Publication of DE69934415D1 publication Critical patent/DE69934415D1/de
Application granted granted Critical
Publication of DE69934415T2 publication Critical patent/DE69934415T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726Lectins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Plant Pathology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69934415T 1998-08-24 1999-08-24 Neuartiges collectin Expired - Lifetime DE69934415T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23761198 1998-08-24
JP23761198 1998-08-24
PCT/JP1999/004552 WO2000011161A1 (fr) 1998-08-24 1999-08-24 Nouvelle collectine

Publications (2)

Publication Number Publication Date
DE69934415D1 true DE69934415D1 (de) 2007-01-25
DE69934415T2 DE69934415T2 (de) 2007-09-27

Family

ID=17017889

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934415T Expired - Lifetime DE69934415T2 (de) 1998-08-24 1999-08-24 Neuartiges collectin

Country Status (14)

Country Link
US (3) US20070020729A1 (de)
EP (1) EP1108786B1 (de)
JP (1) JP4441118B2 (de)
KR (1) KR100633221B1 (de)
CN (1) CN1320164A (de)
AT (1) ATE348158T1 (de)
AU (1) AU751173B2 (de)
CA (1) CA2340934C (de)
CY (1) CY1106041T1 (de)
DE (1) DE69934415T2 (de)
DK (1) DK1108786T3 (de)
ES (1) ES2279629T3 (de)
PT (1) PT1108786E (de)
WO (1) WO2000011161A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2331107T3 (es) 2000-02-14 2009-12-22 Fuso Pharmaceutical Industries Ltd. Nuevos receptores captadores.
EP1440083B1 (de) 2001-10-25 2013-01-02 Medical Research Council Moleküle
CA2724638C (en) 2008-05-27 2020-02-18 Dako Denmark A/S Hybridization compositions and methods comprising a polar aprotic solvent
CN106243229B (zh) * 2008-12-22 2019-09-06 国立大学法人北海道大学 具有三螺旋结构的蛋白质物质及其制造方法
WO2010097655A1 (en) * 2009-02-26 2010-09-02 Dako Denmark A/S Compositions and methods for rna hybridization applications
LT2433082T (lt) * 2009-05-21 2019-09-10 Polaris Solutions, Ltd. Maskuojantis elementas
JPWO2011108281A1 (ja) * 2010-03-04 2013-06-20 扶桑薬品工業株式会社 虚血性疾患亢進作用を有するポリペプチド
EP2761028A1 (de) 2011-09-30 2014-08-06 Dako Denmark A/S Hybridisierungszusammensetzungen und -verfahren mit formamid
US11118226B2 (en) 2011-10-21 2021-09-14 Agilent Technologies, Inc. Hybridization compositions and methods
CN115925861B (zh) * 2022-10-13 2024-02-20 海南大学 驼背鲈C-型凝集素CaCTL4E基因、蛋白、载体、重组细胞及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK570485D0 (da) * 1985-12-10 1985-12-10 Novo Industri As Humant conglutinin
US5270199A (en) * 1987-08-20 1993-12-14 The Children's Medical Center Corporation Human mannose-binding protein
CA2400143C (en) * 1995-08-17 2009-05-12 Fuso Pharmaceutical Industries, Ltd. Recombinant conglutinin and producing method thereof
JPH09238683A (ja) * 1996-03-12 1997-09-16 Eijiin Kenkyusho:Kk ウェルナー症候群の原因遺伝子の存在する領域にある新規ws−3遺伝子及びその遺伝子がコードするタンパク質
WO1998055614A2 (en) * 1997-06-04 1998-12-10 Genetics Institute, Inc. Secreted proteins and polynucleotides encoding them

Also Published As

Publication number Publication date
JP4441118B2 (ja) 2010-03-31
US20070020729A1 (en) 2007-01-25
US20130230918A1 (en) 2013-09-05
DK1108786T3 (da) 2007-04-16
CA2340934C (en) 2009-02-17
AU5305699A (en) 2000-03-14
EP1108786A1 (de) 2001-06-20
ES2279629T3 (es) 2007-08-16
EP1108786B1 (de) 2006-12-13
ATE348158T1 (de) 2007-01-15
WO2000011161A1 (fr) 2000-03-02
PT1108786E (pt) 2007-02-28
EP1108786A4 (de) 2003-08-06
AU751173B2 (en) 2002-08-08
KR20010085583A (ko) 2001-09-07
CN1320164A (zh) 2001-10-31
DE69934415T2 (de) 2007-09-27
CA2340934A1 (en) 2000-03-02
CY1106041T1 (el) 2011-04-06
KR100633221B1 (ko) 2006-10-11
US20110065177A1 (en) 2011-03-17

Similar Documents

Publication Publication Date Title
DE60021497D1 (de) Menschliche, für zyklische Nukleotide spezifische Phosphodiesterase
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
RS50364B (sr) Modifikovani faktor viii
BR9913360A (pt) Oxidase de urato
DE69636495D1 (de) Multi-tumor abweichende wachstumsgene
CY1106041T1 (el) Καινοφανης συλλεκτινη
IT1283876B1 (it) Molecole chimeriche ribozima-snrna ad attivita' catalitica per rna a localizzazione nucleare
WO1995003406A3 (en) Enhancement of oligonucleotide inhibition of protein production, cell proliferation, and/or multiplication of infectious disease pathogens
NZ508439A (en) Novel endometriosis-associated gene
GB0020331D0 (en) Enzyme
ATE353913T1 (de) Neue collectine
EP0816504A3 (de) Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen
CO4480058A1 (es) Genes codificantes y procedimiento de expresion de una nueva enzima: ftalil amidasa
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
EA199900893A1 (ru) Бактериальные плазмиды
ATE452903T1 (de) Modifizierte peptide und deren verwendung zur behandlung von autoimmunkrankheiten
DE69534738D1 (de) Leukocyten-aktivierender Faktor
BR0107799A (pt) Proteìna de interação de wt1 wtip
PT1537210E (pt) Inibicao de oliconucleotidos decoy de expressao cd-40
ATE301199T1 (de) Beta-primeverosidase gen
ECSP982465A (es) Plasmidos bacterianos

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803